Overview

Sodium Creatine Phosphate in Heart Valve Surgery

Status:
Unknown status
Trial end date:
2018-12-31
Target enrollment:
0
Participant gender:
All
Summary
To explore the effect of intraoperative sodium creatine phosphate on myocardial protection in patients undergoing valve surgery
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Chinese Academy of Medical Sciences, Fuwai Hospital
Treatments:
Phosphocreatine
Criteria
Inclusion Criteria:

- valvular disease patients requiring valvular replacement or repair surgery with
cardiopulmonary bypass(CPB)

Exclusion Criteria:

- thoracoscopic valve surgery

- other organ dysfunction: such as cancer, organ failure, severe anemia, infection

- patients with mental disorders

- coagulopathy, active ulcer, ischemic or hemorrhagic stroke (within 6 months), trauma